Pediatric Optic Pathway Gliomas Resource Utilization and Prevalence in the OptumLabs Data Warehouse

Theo N Stoddard-Bennett1, Fei Yu, Samuel J Spiegel

  • 1Department of Ophthalmology (TNS-B, FY, ALC, SLP), Stein Eye Institute, University of California, Los Angeles, California; Department of Biostatistics (FY), University of California Los Angeles, Fielding School of Public Health, Los Angeles, California; Department of Ophthalmology (SJS), Gavin Herbert Eye Institute, University of California Irvine, Irvine, California; Department of Medicine Statistics Core (CFP), David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California; and Department of Ophthalmology (MXR), Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Summary

Pediatric optic pathway gliomas (OPGs) affect approximately 4.6-6.1 per 100k children, with most cases not requiring treatment. Annual eye exams like optical coherence tomography (OCT) and visual field (VF) testing are common for monitoring OPGs.